The Cardio IQ® Insulin Resistance Panel with Score test contains 1 test with 3 biomarkers.
Cardio IQ® Insulin Resistance Panel with Score
Includes
Insulin, Intact, LC/MS/MS
C-Peptide, LC/MS/MS
Insulin Resistance Score
Patient Preparation
Overnight fasting is required
Clinical Significance
The determination of insulin in serum is primarily used for the diagnosis of glycemic disorders in diabetic and pre-diabetic patients in the assessment of insulin resistant syndromes. Insulin is synthesized by the pancreatic beta cell as a precursor, proinsulin. Proinsulin is processed to insulin and C-peptide, a contiguous peptide between the insulin A and B chains, as it passes through the cell. The C-peptide in the proinsulin ensures correct folding and processing of proinsulin as it passes through the cell. Both insulin and C-peptide are released together from the beta cells in response to increased glucose levels. Because of differences in half-life and hepatic clearance, peripheral blood levels of C-peptide and insulin are no longer equimolar but remain highly correlated. A steady-state plasma glucose test in individuals undergoing an insulin suppression test to assess insulin resistance found that the combination of insulin and C-peptide was a better indicator of insulin resistance than either one individually.
The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
CARDIO IQ(R) INSULIN RESISTANCE PANEL WITH SCORE #36509
3 Biomarkers - Average Process Time*: 6 to 7 days
Biomarkers 3
C-PEPTIDE, LC/MS/MS
INSULIN RESISTANCE SCORE
INSULIN, INTACT, LC/MS/MS
*Process times are an estimate and are not guaranteed. The lab may need additional time due to weather, holidays, confirmation/repeat testing, or equipment maintenance.